Skip to main content Accessibility help

Safety and Side-effects of Alprazolam Controlled Study in Agoraphobia with Panic Disorder

  • G. H. O'Sullivan (a1), H. Noshirvani (a1), M. Basoglu (a1), I. M. Marks (a1), R. Swinson (a2), K. Kuch (a2) and M. Kirby (a2)...



The widespread use of benzodiazepines has led to increasing recognition of their unwanted effects. The efficacy of alprazolam and placebo in panic disorder with agoraphobia, and the side-effect and adverse effect profiles of both drug groups were measured.


In London and Toronto 154 patients who met DSM–III criteria for panic disorder with agoraphobia were randomised to alprazolam or placebo. Subjects in each drug group also received either exposure or relaxation. Treatment was from weeks 0 to 8 and was then tapered from weeks 8 to 16.


Mean alprazolam dose was 5 mg daily. Compared with placebo subjects, alprazolam patients developed more adverse reactions (21 % v. 0%) of depression, enuresis, disinhibition and aggression; and more side-effects, particularly sedation, irritability, impaired memory, weight loss and ataxia. Side-effects tended to diminish during treatment but remained significant at week 8. Despite this, the drop-out rate was low.


Alprazolam caused side-effects and adverse effects during treatment but many patients were willing to accept these.


Corresponding author

Dr G. H. O'Sullivan, MOST, 5 Camberwell Church Street, London SE5 8QU


Hide All
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.
Aranko, K., Mattila, M. J. & Bordignon, D. (1985) Psychomotor effects of alprazolam and diazepam during acute and subacute treatment and during followup phase. Acta Pharmacologica Toxicologica, 56, 346372.
Ashton, H. (1984) Benzodiazepine withdrawal: an unfinished story. British Medical Journal, 288, 11351140.
Ballenger, J. C., Burrows, G. D., Dupont, R. L., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicentre trial. 1 Efficacy in the short term. Archives of General Psychiatry, 45, 413422.
Balter, M. D., Manheimer, D. I., Mellinger, G. D., et al (1984) A cross-national comparison of anti-anxiety/sedative drug use. Current Medical Research and Opinion, 8 (suppl. 4), 520.
Baso$gblu, M., Marks, I., Kil$ic, C., et al (1994) Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry, 164, 652659.
Bellantuono, C., Reggi, V., Tognoni, G., et al (1980) Benzodiazepines: clinical pharmacology and therapeutic use. Drugs, 19, 195219.
Bixler, E. O., Kales, A., Manfredi, R. L., et al (1991) Next-day memory impairment with triazolam use. Lancet, 337, 827831.
Block, R. I. & Berchou, R. (1984) Alprazolam and lorazepam effects on memory acquisition and retrieval processes. Pharmacology, Biochemistry and Behavior, 20, 233241.
Charney, D. S. & Heninger, G. R. (1985) Noradrenergic function and the mechanism of action of antianxiety treatment. Archives of General Psychiatry, 42, 473481.
Chouinard, G., Annable, L., Fontaine, R., et al (1982) Alprazolam in the treatment of generalized anxiety and panic disorders. Psychopharmacology, 77, 229233.
Cohen, S. I. (1992) Phobic disorders and benzodiazepines in the elderly. Letter to British Journal of Psychiatry, 160, 135.
Dunner, D. L., Ishiki, D., A very, D. H., et al (1986) Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: A controlled study. Journal of Clinical Psychiatry, 47, 458460.
Edwards, J. D. (1981) Adverse effects of antianxiety drugs. Drugs, 22, 495514.
Feighneer, J. P. (1987) Impact of anxiety therapy on patients' quality of life. American Journal of Medicine, 82 (suppl. 5A), 1419.
File, S. E. (1981) Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology, 73, 240245.
Gaind, R. N. & Jacoby, R. (1978) Benzodiazepines causing aggression. In Current Themes in Psychiatry (eds Gaind, R. N. & Hudson, B. L.), pp. 371379. London: Macmillan.
Greenberg, H. R. (1971) Inhibition of ejaculation by chlorpromazine. Journal of Nervous and Mental Disease, 152, 364366.
Hamilton, M. (1959) The assessment of anxiety state by ratings. British Journal of Medical Psychology, 32, 5055.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.
Hughes, J. M. (1964) Failure to ejaculate with chlordiazepoxide. American Journal of Psychiatry, 121, 610611.
Kotin, J., Wilbert, D. E., Berburg, D., et al (1976) Thioridazine and sexual dysfunction. American Journal of Psychiatry, 133, 8285.
Lader, M. (1983) Benzodiazepines, psychological functioning and dementia. In Benzodiazepines Divided (ed. Trimble, M. R.), pp. 309325. Chichester: Wiley.
Lader, M. (1985) Achieving treatment goals: limitations of therapies. Internal Medicine for the Specialist (special issue), 29.
Lader, M., Curry, S. & Baker, W. (1980) Physiological and psychological effects of chlorazepate in man. British Journal of Clinical Pharmacology, 9, 8389.
Levine, J. & Schooler, N. R. (1986) SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacology Bulletin, 22, 343381.
Lydiard, R. B., Howell, E. F. & Laraia, M. T. (1987) Sexual side effects of alprazolam. American Journal of Psychiatry, 144, 254255.
Marks, I. M., Swinson, R. P., Basoglu, M., et al (1993) Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776787.
Munjack, D. J. & Crocker, B. (1986) Alprazolam induced ejaculatory inhibition. Journal of Clinical Psychopharmacology, 6, 5758.
Monteiro, W. O., Noshirvani, H. F., Marks, I. M., et al (1987) Anorgasmia with clomipramine in obsessive compulsive disorder. A controlled trial. British Journal of Psychiatry, 151, 189195.
Noyes, R., Du Pont, R. L., Pecknold, J. C., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicentre trial. II Patient acceptance, side effects and safety. Archives of General Psychiatry, 45, 423428.
O'Donnell, V. M., Balkin, T. J. & Andrade, J. R. (1988) Effects of triazolam on performance and sleep in a model of transient insomnia. Human Performance (suppl. 3), 145160.
Oswald, I. (1989) Triazolam syndrome 10 years on. [Letter]. Lancet, 334, 451452.
Remick, R. A., Fleming, J. A. E., Buchanan, R. A., et al (1985) A comparison of the safety and efficacy of alprazolam and desipramine in moderately severe depression. Canadian Journal of Psychiatry, 30, 597601.
Rizley, R., Kahn, R. J., McNair, D. M. (1986) Comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. Psychopharmacology Bulletin, 22, 167172.
Rosenbaum, J. F., Woods, S. W., Groves, J. E., et al (1984) Emergence of hostility during alprazolam treatment. American Journal of Psychiatry, 141, 792793.
Sangal, R. (1985) Inhibited female orgasm as a side effect of alprazolam. American Journal of Psychiatry, 142, 12231224.
Schuckit, M. A. (1984) Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, 2nd edn. New York: Plenum.
Shader, R. I. & Greenblatt, D. J. (1983) Triazolam and anterograde amnesia: all is not well in the z-zone. Journal of Clinical Psychopharmacology, 3, 273.
Smiley, A. (1987) Effects of minor tranquillizers and antidepressants on psychomotor performance. Journal of Clinical Psychiatry, 48 (suppl. 12), 2228.
Spitzer, R. L. & Williams, J. B. W. (1983) Structured Clinical Interview for DSM–III, Upjohn Version (SCID-UP). New York: Biometric Research Division, New York State Psychiatric Institute.
Uhde, T. W., Tancer, M. E. & Shea, C. A. (1988) Sexual dysfunction related to alprazolam treatment of social phobia. American Journal of Psychiatry, 145, 531532.
Wolkowitz, O. M., Weingartner, H., Thompson, K., et al (1987) Diazepam-induced amnesia. American Journal of Psychiatry, 144, 2529.

Safety and Side-effects of Alprazolam Controlled Study in Agoraphobia with Panic Disorder

  • G. H. O'Sullivan (a1), H. Noshirvani (a1), M. Basoglu (a1), I. M. Marks (a1), R. Swinson (a2), K. Kuch (a2) and M. Kirby (a2)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Safety and Side-effects of Alprazolam Controlled Study in Agoraphobia with Panic Disorder

  • G. H. O'Sullivan (a1), H. Noshirvani (a1), M. Basoglu (a1), I. M. Marks (a1), R. Swinson (a2), K. Kuch (a2) and M. Kirby (a2)...
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *